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Negative symptoms in schizophrenia have been grouped into 
the 2 factors of apathy and diminished expression, which 
might be caused by separable pathophysiological mecha-
nisms. Recently, it has been proposed that apathy could be 
due to dysfunctional integration of reward and effort dur-
ing decision making. We asked whether apathy in particu-
lar is associated with stronger devaluation (“discounting”) 
of monetary rewards that require physical effort. Thirty-
one patients with schizophrenia and 20 healthy control 
participants performed a computerized effort discounting 
task in which they could choose to exert physical effort on 
a handgrip to obtain monetary rewards. This procedure 
yields an individual measure for the strength of effort dis-
counting. The degree of effort discounting was strongly 
correlated with apathy, but not with diminished expression. 
Importantly, the association between apathy and effort dis-
counting was not driven by cognitive ability, antipsychotic 
medication, or other clinical and demographic variables. 
This study provides the first evidence for a highly specific 
association of apathy with effort-based decision making in 
patients with schizophrenia. Within a translational frame-
work, the present effort discounting task could provide a 
bridge between apathy as a psychopathological phenom-
enon and established behavioral tasks to address similar 
states in animals.
Key words: negative symptoms/effort-based decision 
making/cost-benefit calculation
Introduction
Negative symptoms are a core feature of schizophre-
nia and have a strong impact on functional outcome.1–4 
Although the detrimental functional consequences of 
negative symptoms are well recognized, causal mech-
anisms still remain largely unknown, hindering the 
development of effective treatment. Recently, a consensus 
has emerged that negative symptoms can be grouped into 
2 factors,5–7 which we refer to as apathy and diminished 
expression. It has been proposed that these 2 dimensions 
could be caused by partly different pathophysiological 
mechanisms.6,8
Apathy can be defined as a reduction of motivation 
and/or goal-directed behavior.9 Reward is considered 
a driving factor for both motivation and goal-directed 
behavior. Accordingly, deficits in reward learning,10,11 
the neural representation of reward anticipation,12 and 
the ability to form mental representations of prospective 
rewards13 have been put forward as correlates of apathy. 
More recently, research into negative symptoms has pro-
posed that goal-directed behavior is not solely driven by 
the reward component itself, but also the effort required 
to obtain the reward.14–16 Consequently, an overweigh-
ing of effort costs in decision making could result in a 
decrease of goal-directed behavior and present clinically 
as apathy. Two important studies report dysfunctions of 
effort-based decision making in patients with schizophre-
nia, but the expected symptom-level link between apathy 
and choice behavior was not observed in patients.14,15
In this study, we used an approach informed by behav-
ioral economics to specifically address the relation-
ship between negative symptoms and making decisions 
involving widely different levels of real and pure physi-
cal effort.17,18 Specifically, we adapted a standard choice 
paradigm19 to provide a subjective measure of how mon-
etary reward is devalued in proportion to a requirement 
for handgrip force (effort discounting).20 In other words, 
we measured one’s propensity to refrain from engaging in 
a rewarded but effortful behavior. We hypothesized that 
steeper effort discounting could account for the reduc-
tion of motivation and goal-directed behavior in apa-
thetic patients relative to a healthy control (HC) group 
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and to patients with lower apathy levels. In particular, we 
hypothesized that increased effort discounting would be 
correlated with apathy but not with diminished expres-
sion ratings.
Methods
Participants
Thirty-one individuals meeting Diagnostic and 
Statistical Manual of  Mental Disorders, Fourth Edition 
(DSM-IV)21 criteria for schizophrenia (n  =  25) or 
schizoaffective disorder (n = 6, no mood episode) and 20 
HC participants took part in the study. The local Ethics 
committee approved the study, and all participants gave 
written informed consent. Patients were clinically and 
pharmacologically stable inpatients at the end of  their 
hospitalization (n  =  25) or outpatients (n  =  6) treated 
at the Psychiatric Hospital, University of  Zurich. Please 
note that the average inpatient stay for patients with 
schizophrenia in Swiss psychiatric hospitals is above 
40 days,22 thus many of  our inpatients would be treated 
as outpatients in other healthcare systems. Importantly, 
inpatients participated in a multimodal treatment pro-
gram and were encouraged to engage in activities out-
side the hospital, which allowed assessment of  negative 
symptoms. Patients were excluded if  (1) daily lorazepam 
dosage exceeded 1 mg, (2) florid positive symptoms were 
present (Positive and Negative Syndrome Scale; PANSS;23 
any positive subscale item score >4), (3) extrapyramidal 
side effects were observed by the treating clinician, or 
(4) additional DSM-IV axis-1 or axis-2 diagnostic cri-
teria were met (according to the treating clinician). To 
confirm axis-1 diagnosis in patients, exclude comorbid 
axis-1 disorders and ensure the absence of  axis-1 disor-
ders in the HC group, we used the Mini-International 
Neuropsychiatric Interview.24
Assessment of Psychopathology and Cognition
For psychopathological assessment, the following 
instruments were used: Brief  Negative Symptom Scale 
(BNSS),25 Scale for the Assessment of Negative Symptoms 
(SANS),26 PANSS, Global Assessment of Functioning 
scale,27 Personal and Social Performance Scale,28 and 
the Calgary Depression Scale for Schizophrenia.29 The 
BNSS was translated into German by the senior author 
(see supplementary material), who trained and regularly 
supervised all raters. The scores for the 2 negative symp-
tom factors in the BNSS were calculated according to the 
2-factor structure proposed by the original authors (see 
supplementary table S1).30
A composite cognitive ability score was computed as 
the mean of z-transformed scores (based on HC group 
data) of the following cognitive tests: verbal learn-
ing (German version of the Auditory Verbal Learning 
Memory Test),31 verbal and visual short-term and work-
ing memory (Digit Span,32 Corsi block-tapping test)33, 
processing speed (Digit-Symbol Coding),34 planning 
(Tower of London),35 and semantic and phonemic flu-
ency (animal naming, s-words).36
Experimental Procedure: Effort Discounting Task
The procedure constitutes an adapted version of a recently 
described effort discounting task20 (figure 1). An isomet-
ric dynamometer (Sensory-Motor Systems Laboratory 
ETH Zurich; measuring range: 0–600 Newton) was used 
to assess physical effort. To determine maximum vol-
untary contraction (MVC), participants were asked to 
squeeze the handgrip with their dominant hand as hard 
as possible for 2 consecutive trials of 3.5 s without visual 
feedback of their grip strength. To approximate realistic 
steady-state values, MVC corresponded to the median 
force value of the period 1–3.5 s of these 2 maximum 
effort trials.
During the task, participants then made a series 
of choices between a default small amount of money 
available without any effort and an alternative larger 
amount that was conditional on physical effort exertion. 
Participants indicated their preference by button-press. 
The effortful option was manipulated over successive 
trials in terms of reward (1.5, 2, 2.5, 3, 5 Swiss Francs; 
Fig. 1. Schematic of the effort discounting task. (A) Presentation of choice options (no time limit). (B) Fixation cross (4 s). (C) Effort 
exertion period (3.5 s). (D) Feedback period (3 s).
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CHF; 1 CHF ≈ 1.09 $) and effort (40, 60, 80, 100% MVC), 
whereas the default effortless option always yielded 1 
CHF. Each option pair was randomly presented 4 times, 
resulting in a total of 80 trials, which were divided in to 2 
blocks. Time for choice was not restricted. For a minority 
of participants and effort levels, reward had to be itera-
tively decreased or increased in additional trials for more 
accurate estimation of effort discounting indices (see the 
“Data Processing” section).
The effort level of the chosen option had to be imple-
mented after each choice in constant 3.5-s effort exer-
tion periods with visual feedback (critical measurement 
period: 1–3.5 s). Importantly, the duration of the effort 
period was also implemented if  the default effortless 
option was chosen. Thus, time costs were held constant 
between the effortful and effortless options. The individ-
ually adjusted effort levels assured that the participants 
were physically capable of performing each effort level. 
To exclude effects of loss aversion, participants were 
given the default reward of 1 CHF when failing to hold 
the required effort level (the number of failed trials was 
low and thus remained in the analyses as choice data; 
M  =  1.2, SD  =  1.68). To control for effects of fatigue, 
we collected an additional MVC measure (identical to 
the one described above) after finishing the experiment. 
Five of the total completed trials were randomly drawn 
and paid out after completion of the task. No feedback 
about earnings was given during the task. The task was 
implemented using the MATLAB toolboxes Cogent 2000 
and Cogent Graphics and presented on a 19-in. computer 
screen.
Visual Analog Scales: Monetary Reward Pleasure and 
Perceived Effort
After the effort discounting task, participants provided 
self-report measures of anticipated monetary reward 
pleasure (how much pleasure they would feel when they 
would unexpectedly find a 50 CHF bill on the street) and 
effort perception (how strenuous they perceived 40, 60, 
80, and 100% MVC) on visual analog scales.
Data Processing
Intuitively, the effort discounting task aims to identify 
the minimum amount of payment each subject demands 
before agreeing to exert a given effort. More precisely, 
this is the amount of payment that makes them indiffer-
ent between the effortless and a given effortful option. To 
extract the indifference points, a logistic function was fit-
ted to the fraction of effortful choices across all reward 
levels (figure 2A). Overall model fit (R2) was not different 
between the patient and HC group (t(49) = 1.16, P = .25). 
These indifference values (figure 2B) then served to cap-
ture how the different effort levels (40, 60, 80, and 100% 
MVC) reduce (ie, “discount”) value in each participant. 
To do so, the default reward (1 CHF) was divided by the 
respective indifference amount, which yields a measure 
of relative subjective value (SV; figure 2C). Indifference 
points were estimated online during the task and if  no 
preference reversal was observed, the reward amount 
for the effortful option was iteratively increased (7/10/20 
CHF) or decreased (1.20/1.10/1.05 CHF) in additional 3 
steps until choice behavior reversed.
Fig. 2. Effort discounting. (A) Choice data from 1 participant and illustration of how we estimate the indifference points. In particular, 
we used a logistic function to interpolate the precise amount of reward that each participant required in order to be completely 
indifferent between the effortful and effortless options, ie, in order for them to choose each option at 50% probability (*). (B) Indifference 
points plotted against all effort levels in the example participant shown in (A). (C) Discount curve of the same participant. The relative 
subjective values are calculated by dividing the default amount (1 CHF) by the indifference amount. The area under the curve of the 
relative subjective values constitutes our main dependent variable of overall individual effort discounting.
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In discounting paradigms, the indicator for the degree 
of discounting has traditionally been the fitted param-
eter of a model with one free parameter that modulates 
the steepness of the curve.37 However, debate has recently 
arisen about the appropriate shape of that curve in effort 
discounting.20 To circumvent this issue and capture indi-
vidual effort discounting in an unbiased way, we com-
puted the area under the curve (AUC) of the relative 
SVs over the 4 effort conditions as the measure for over-
all discounting (figure 2C). A smaller AUC corresponds 
to steeper effort discounting. This procedure is entirely 
driven by data but has comparable sensitivity to a one-
parameter discount model.38 In sum, for each participant, 
we have thus a measure of overall discounting (AUC) and 
measures for the 4 effort levels separately (relative SVs).
Statistical Analyses
To test our main hypothesis, we computed Pearson cor-
relations (r) between negative symptoms (apathy and 
diminished expression) and overall effort discount-
ing (AUC). To further test for a significant difference 
between these correlations, we computed a t statistic.39 
In addition, we calculated Bayes factors (BF10) on these 
correlations,40 allowing us to quantify evidence in favor 
of the null hypotheses in the case of nonsignificant cor-
relations. To control for confounds, partial correlations 
were computed.
We then pursued a categorical approach to compare 
effort discounting of the HC group to LOW-APATHY 
and HIGH-APATHY patients using the median split 
on the BNSS apathy score (Mdn  =  16). We conducted 
a 4 (relative SVs for the 4 effort levels) × 3 (HC, LOW-
APATHY, HIGH-APATHY) mixed design ANOVA to 
investigate overall group effects and additional ANOVAs 
to detect specific effects.
If  variables were non-normally distributed according to 
Shapiro-Wilk tests, nonparametric statistics (Spearman 
correlation rs, Mann-Whitney U test) were applied.
Results
Sample Characteristics
Group characteristics and group comparisons are 
depicted in table 1.
Effort Task Performance
All participants demonstrated preference reversal for 
all effort levels and showed overall effort discounting 
(decreasing relative SVs with increasing effort), which 
indicates that they processed both effort and reward 
information. For raw choice data, see supplementary 
figure S1. The HC and the patient group did not differ 
significantly with regard to MVC before the experiment, 
time to reach MVC, fatigue, and final payout (table 1). 
None of the groups showed significant fatigue (decline in 
MVC before vs after the experiment; P > .23). There was 
no significant correlation of apathy with MVC before the 
experiment (r(29) = .12, P = .51), fatigue (r(29) = −.18, 
P = .34), final payout (r(29) = −.30, P = .10), and total 
number of trials completed (rs(29) = −.17, P = .36).
Association of Negative Symptoms With Effort 
Discounting
We used AUC of the relative SVs to determine overall 
effort discounting. Regarding our main hypothesis, we 
found a highly significant correlation between apathy and 
effort discounting (r(29) = −.67, P < .0001; figure 3A). In 
contrast, the correlation between diminished expression 
and effort discounting was not significant (r(29) = −.14, 
P  =  .45; figure  3B). Importantly, these 2 correlations 
between symptomatology (apathy vs diminished expres-
sion) and effort discounting were significantly different 
(t(28) = 4.57, P < .0001). Strikingly, the differential corre-
lations arose even though, in line with prior studies on the 
structure of negative symptoms.5,7,41,42, apathy and dimin-
ished expression were significantly correlated with each 
other (r(29) = .58, P < .01). Thus, our results indicate that 
effort discounting is more strongly associated with apathy 
than diminished expression.
To quantify the relative evidence for the null (H0) or 
the alternative hypothesis (H1) in these correlations, we 
performed “Bayesian hypothesis tests”.40 These analy-
ses revealed a BF10 of 624.81 in the correlation between 
apathy and effort discounting and a BF10 of 0.18 in the 
correlation between diminished expression and effort 
discounting. By accepted convention,43 the first implies 
“decisive evidence” for the H1 (BF10 > 100), whereas the 
latter implies “substantial evidence” for the H0 (BF10: 
0.1–0.33). In other words, there is decisive evidence for 
the association between apathy and effort discounting 
and substantial evidence for the lack of an association 
between diminished expression and effort discounting.
We next computed a nonparametric partial correla-
tion between apathy and effort discounting, controlling 
for depressive symptoms, MVC, fatigue, chlorpromazine 
equivalents, cognitive ability, age, education, and income. 
Importantly, the association between clinically assessed 
apathy and our measure of effort discounting remains 
highly significant even when we control for variance in 
all the considered factors (rs(21)  =  −.59, P < .01) indi-
cating that these factors cannot account for the observed 
association.
Association of Covariates With Effort Discounting
We also conducted further correlational analyses 
between the covariates in our study and effort discount-
ing (table 2; see supplementary table S2 for correlations 
with SVs at each effort level). Three main results from 
these analyses have to be highlighted: first, the main find-
ing of  the study—apathy but not diminished expression is 
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associated with effort discounting—also holds when 
SANS is used to quantify symptoms. Second, no signifi-
cant correlations with positive symptoms, depression, 
and chlorpromazine equivalents44 were obtained. Finally, 
in both, patient and HC groups, cognition, education, 
income, and MVC were not significantly associated with 
effort discounting.
Self-report Measures of Monetary Reward Valuation 
and Perceived Effort
There were no significant effects of group (HC, LOW-
APATHY, HIGH-APATHY) on self-report measures 
of either monetary reward valuation or perceived effort 
(see supplementary figures S2A and S2B). To investi-
gate possible antecedents of increased effort discount-
ing in apathetic patients, we correlated effort discounting 
and apathy with the perceived effort in the 4 effort lev-
els (AUC) and the self-report measure of anticipated 
monetary reward pleasure. First, none of the measures 
for perceived effort were associated with apathy in the 
patient group (all P > .46, all BF10 < 0.18). This indicates 
that altered effort-based decision making in apathetic 
states does not seem to be primarily driven by changes 
in the pure psychophysical translation of physical force 
to sensation. Second, anticipated pleasure derived from 
monetary reward was negatively correlated with apathy 
(r(29)  =  −.43, P  =  .02). Furthermore, effort discount-
ing was associated with less anticipated pleasure, but 
not with perceived effort (see table  2). These data sug-
gest that the relationship between apathy and effort dis-
counting in patients might be partly driven by a reduction 
in anticipated pleasure. However, when controlling for 
reward pleasure in a partial correlation between apathy 
and effort discounting, the resulting coefficient remains 
highly significant (r(28) = −.59, P = .001), suggesting that 
Table 2. Bivariate Correlations
Effort Discounting 
(AUC)
Psychopathology
 BNSS apathy −0.67***
 BNSS diminished expression −0.14
 SANS apathya −0.56**
 SANS diminished expressiona −0.17
 PANSS positive factorb −0.26
 PANSS negative factorb −0.25
 GAF 0.51**
 PSP (total) 0.58**
 CDSS (total) −0.11d
Number of hospitalizations 0.01d
Chlorpromazine equivalents (mg/day) −0.12
Cognitionc
 Composite cognitive ability SZ 0.03
HC −0.04
 Income SZ 0.10d
HC −0.09
Maximum voluntary  
contraction (MVC)
SZ −0.29
HC −0.35
Anticipatory reward  
pleasure (VAS)
SZ 0.41*
HC −0.30
Perceived effort  
(overall, VAS)
SZ −0.26
HC 0.04
Note: Abbreviations are explained in the first footnote to tables 
1. AUC, area under the curve; SZ, schizophrenia patient group; 
VAS, Visual Analogue Scale.
aApathy = Avolition/Apathy, Anhedonia/Asociality; diminished 
expression = Affective Flattening or Blunting, Alogia.
bPositive factor = P1, P3, P5, G9; negative factor = N1, N2, N3, 
N4, N6, G7.
cCognition data have been z-transformed based on the data of the 
HC group for each test separately. The composite cognitive ability 
score was computed as the mean of the z-transformed test scores 
on subject level.
dSpearman correlations (rs).
*P < .05, **P < .01, ***P < .001.
Fig. 3. Bivariate Pearson correlation (including significance test and Bayes factor) of apathy (A) and diminished expression (B) with the 
effort discount factor, measured as the area under the curve of the relative subjective values plotted against the 4 effort levels. (C) Group 
level effort discounting plotted against all effort levels (*P < .05, **P < .01).
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reward pleasure fails to completely account for the rela-
tion between apathy and effort discounting.
Group Differences in Effort Discounting
To assess how effort discounting in high and low apathy 
patients compares to, and differs from, effort discount-
ing in HC, we median-split the patient group. Group 
level results are depicted in figure 3C. In the 4 (relative 
SVs for the 4 effort levels) × 3 (HC, LOW-APATHY, 
HIGH-APATHY) mixed design ANOVA, we observed 
a significant main effect of group (F(2,48)  =  5.81, P < 
.01) and effort (F(3,48) = 119.33, P < .0001), and a nearly 
significant interaction term (F(6,48)  =  2.12, P = .054). 
Follow-up 4 × 2 mixed design ANOVAs showed that the 
HC and the LOW-APATHY group did not significantly 
differ (F(1,33)  =  0.04, P  =  .84), whereas the HIGH-
APATHY group was significantly different from both the 
LOW-APATHY and HC group (F(1,29) = 8.40, P < .01; 
F(1,34) = 10.90, P < .01).
We further computed 1-way ANOVAs for all the 
effort levels (factor group: HC, LOW-APATHY, HIGH-
APATHY) and found significant group effects in the 
40, 60, and 80% effort levels (F(1,33)  =  5.22, P < .01; 
F(1,33) = 4.15, P < .05; F(1,33) = 5.45, P < .01). Post hoc 
comparisons using the Fisher LSD test further revealed 
significant differences (P < .05) indicative of stronger 
effort discounting with more apathy in the 60% and 80% 
condition (HIGH-APATHY group vs. both the HC and 
LOW-APATHY group). Moreover, in the 40% condition, 
both patient groups discounted significantly more than 
the HC group. In sum, the HIGH-APATHY group shows 
stronger effort discounting than the LOW-APATHY and 
HC group across a broad effort range, whereas the only 
effort level where both patient groups can be statisti-
cally distinguished from the HC group is the low 40% 
effort level.
To investigate whether effort discounting was stable 
over the course of the experiment, we split choice data 
into 4 blocks and computed a mixed-design ANOVA on 
fraction of effortful choice. This analysis revealed no sig-
nificant main effect of group (F(2,48) = 2.08, P =  .14), 
a trend-level main effect of block (F(3,48)  =  2.55, 
P  =  .07), and a trend-level block × group interaction 
(F(6,48) = 2.02, P = .07).
Discussion
In the current study, we adapted a paradigm from behav-
ioral economics to investigate how the discounting of 
monetary rewards by physical effort requirements is 
associated with the 2 factors of negative symptoms in 
schizophrenia—apathy and diminished expression. We 
have several key findings to report. First and most impor-
tantly, increased effort discounting was strongly corre-
lated with apathy but not with diminished expression. 
This effect was not due to depressive symptoms, grip 
strength, fatigue, antipsychotic medication dosage, cogni-
tive impairment, age, education, and income. Second, our 
data suggest that increased effort discounting in apathy 
is due to deficits in both weighing of effort cost in deci-
sion making and the anticipated value of reward. Third, 
group comparisons revealed that only HIGH-APATHY 
patients showed overall differences in effort discounting 
compared with the HC participants.
To our knowledge, this is the first study to show that 
a decreased willingness to exert physical effort for a sec-
ondary reward is negatively correlated with apathy but 
not with diminished expression within a schizophrenia 
sample. Two important recent studies also reported a 
decreased willingness to exert effort for monetary rewards 
in schizophrenia.14,15 Our results are generally in line with 
those 2 studies, but some differences have to be pointed 
out. In both studies, the effect mainly surfaced in group 
comparisons, either between a patient and a HC group,15 
or 2 patient groups (high and low negative symptoms) and 
a HC group.14 It is of note that Fervaha and colleagues15 
computed across-group correlations (pooling HC and 
patient groups) and found significant results in the asso-
ciation between apathy and effort-based decision making 
using this approach. However, they reported no signifi-
cant correlations within the patient group. Interestingly, 
Gold and colleagues14 also applied the BNSS, but they 
found a significant effect only when the group median 
split was performed with the total negative symptom 
score. No group differences were apparent when the split 
was based on the apathy factor. The authors considered 
this as surprising, because their theoretical framework 
predicted that apathy in particular would be associated 
with effort-based decision making. There are several dif-
ferences in the experimental task between these studies, 
and our current study that might explain the partial dis-
crepancies in the results. First, instead of operational-
izing effort as number of button presses on a computer 
device, we used different levels of physical force exerted 
on a handgrip that was calibrated according to the par-
ticipant’s maximum grip strength. This procedure has 
the advantage that we keep time costs constant and are 
thus able to interpret our results as pure effort discount-
ing independent of delay discounting. Moreover, hand-
grip effort exertion is less likely to be susceptible to an 
influence of motor symptoms, because to our knowledge, 
deficits in pure force application have not been observed 
in patients with schizophrenia.45 In line with this notion, 
we found no difference in MVC and time to reach MVC 
between patients and HCs. Second, we aimed for a task 
structure with easily understandable choice options and 
consequently restricted our cost manipulation to physical 
effort. In the previous studies, both effort and probability 
costs were manipulated, which might lead to a different 
pattern of associations with psychopathology. This dif-
ference between studies could also account for the lack of 
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association between effort discounting and cognitive abil-
ity in our study. Third, our present task incorporates a 
wide range of effort levels from small to maximum, which 
is likely to increase overall sensitivity.
In our group analyses, the combined patient group dif-
fered significantly from HCs only in the 40% effort condi-
tion (figure 3C). HCs discount less in lower effort levels, 
which is consistent with data from a previous study of 
our group.20 Because this pattern is absent in the patient 
group, it can be hypothesized that groups not only show 
differences in overall discounting, but also in the distinct 
form of discounting. It is also noteworthy that group dif-
ferences at the highest effort level are not significant. In 
other words, choice variance and intergroup differences 
seem to decrease with increasing effort.
A decision whether to pursue a potentially rewarding 
behavior when effort is involved is mainly determined 
by subjectively weighing reward against effort costs. In 
this study, we show that, based on choice data, apathy 
is associated with stronger effort discounting. Post-test 
self-report assessments of monetary reward and the 
performed effort levels provide us with additional infor-
mation about how these 2 decision components are per-
ceived. These measures do not reflect in-the-moment 
experience of effort and reward. The perceived effort for 
the 4 subjectively calibrated levels seems to be compara-
ble across groups and not associated with symptoms or 
effort discounting. Self-reported anticipated reward plea-
sure as a measure of reward representation was associ-
ated with both apathy and effort discounting. This is in 
line with the notion that negative symptoms are linked to 
aberrant mental representation of anticipated reward,13 
but stands in contrast to results reported in the discussed 
study by Fervaha and colleagues,15 who used a similar 
measure but did not report any associations with symp-
toms. The significant partial correlation between apathy 
and effort discounting, controlling for perceived reward, 
indicates that the strong relationship between apathy and 
effort discounting can only partially be accounted for by 
degraded reward representations.
Some limitations should be noted in relation to the 
current study. Most of our patients were inpatients with 
moderate levels of negative symptoms. Although all 
inpatients were well stabilized and had the opportunity 
to engage in a variety of activities, it would be impor-
tant to assess generalizability in an outpatient sample. 
Moreover, sample size was modest (n  =  31). Although 
our main effects are strong, one has to consider this in 
particular regarding the missing association between per-
ceived effort and effort discounting or apathy. It has to 
be further mentioned that our effort perception measure 
was assessed post-test, which constitutes a retrospective 
estimation of in-the-moment experience that might be 
influenced by effort expenditure during the task. Future 
studies should assess cigarette smoking characteristics of 
participants because this might affect effort discounting.46 
Finally, our study design only included money, which is a 
secondary reward. Thus, we are not able to generalize our 
results to the discounting of primary rewards (eg, food, 
sex) by effort, which have been shown to be partially pro-
cessed by different brain regions.47 Future studies should 
also investigate how cognitive effort costs are processed 
in relation to apathetic states. It has been suggested that 
cognitive and physical effort might be driven by common 
neural systems.48 We would thus hypothesize that apathy is 
also associated with stronger cognitive effort discounting.
The strong link between effort discounting and the 
negative symptom dimension apathy contributes to a 
translational approach to the symptoms of schizophre-
nia.49,50 Within this framework, a human behavioral task 
as used in the current study provides an essential bridge 
between human psychopathology and behavioral tasks 
to assess related phenomena in animals. For this bridg-
ing role, our task seems to be well suited for 2 main rea-
sons: First, effort discounting in our binary choice task 
shows a strong and specific relationship with the apathy 
dimension, which is not affected by the major possible 
confounds. Second, although our task is not equiva-
lent to rodent tasks, it provides a close approximation. 
Importantly, similar to T-maze tasks in rodents,51 we use 
a simple binary choice independent of probability costs. 
A translational framework including human and animal 
tasks for a specific psychopathological dimension can be 
used to investigate pathophysiological mechanisms and 
pharmacologic compounds for specific symptoms. There 
are already promising causal models for negative symp-
toms—for example, D2 receptor overexpression52—that 
could be investigated with available animal analogs of our 
effort-based choice task. Importantly, human and animal 
effort-based decision-making tasks could contribute to a 
model for preclinical testing of drugs aiming to reduce 
negative symptoms. Currently, most preclinical tests used 
in drug development for schizophrenia are unrelated 
to negative symptoms, such as prepulse inhibition53 or 
amphetamine-induced hyperlocomotion54. In line with 
other authors, we believe that new compounds51,55 should 
be developed in preclinical and clinical studies with tasks 
that have shown a strong relationship with the target 
negative symptom50—as exemplified by the relationship 
between effort-based decision making and apathy.
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